DDRi R&D in CNS Tumors: Landscape & Opportunities

Time: 3:30 pm
day: Day Two

Details:

  •  Understanding the strong rationale for DDRi’s in CNS Tumors
  • Optimizing systematic and efficient experimental drug qualification as a key opportunity to make profound impact on devastating diseases with a strong commercial case

Speakers: